Glutamate/(Creatine and Phosphocreatine) ratio
|
Basic information |
| Metabolite name | Glutamate/(Creatine and Phosphocreatine) ratio |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | NA |
| No. of studies | 21 |
|
Basic information |
| Metabolite name | Glutamate/(Creatine and Phosphocreatine) ratio |
| N/A |
|
N/A |
|
N/A |
| Synonyms | NA |
| No. of studies | 21 |
|
Relationship between Glutamate/(Creatine and Phosphocreatine) ratio and depression (count: 21) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M290 | Type1 | anhedonic group vs. control group | Ventral hippocampus | Wistar rat | Up |
| Study M292 | Type2 | cLH + ECS group vs. cLH group | Hippocampus | Sprague-Dawley rat | Up |
| Study M292 | Type3 | ECS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M294 | Type1 | CMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M299 | Type1 | stroke with depression disorder group vs. stroke without depression group | Frontal lobe | Human | Up |
| Study M309 | Type1 | hypobaric hypoxia group vs. control group | Frontal cortex | Sprague-Dawley rat | Up |
| Study M316 | Type1 | depression group vs. control group | Hippocampus | Human | Up |
| Study M326 | Type2 | MBCT-treated depression group post-treatment vs. pre-treatment | Caudate | Human | Up |
| Study M335 | Type1 | depression group vs. control group | Anterior cingulate cortex | Human | Up |
| Study M338 | Type1 | control group vs. sham group | Hippocampus | Wistar rat | Up |
| Study M338 | Type2 | NC + E group vs. NC group | Hippocampus | Wistar rat | Down |
| Study M338 | Type2 | ALA + E group vs. ALA group | Hippocampus | Wistar rat | Down |
| Study M338 | Type2 | DHA + E group vs. DHA group | Hippocampus | Wistar rat | Down |
| Study M338 | Type2 | EPA + E group vs. EPA group | Hippocampus | Wistar rat | Down |
| Study M350 | Type1 | depression group vs. control group | Medial prefrontal cortex | Human | Down |
| Study M350 | Type1 | depression group vs. control group | Amygdala | Human | Down |
| Study M352 | Type1 | depression group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M367 | Type1 | METH group vs. control group | Frontal cortex | C57BL/6 mouse | Down |
| Study M488 | Type1 | depression group vs. control group | Dorsal anterior cingulate cortex | Human | Down |
| Study M546 | Type1 | CUS offspring group vs. control offspring group, right hippocampus of male offspring | Hippocampus | Sprague-Dawley rat | Up |
| Study M580 | Type1 | CUMS group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M580 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M588 | Type1 | MDD group vs. control group | Dorsal anterior cingulate cortex | Human | Down |
| Study M654 | Type1 | CRS group, after vs. before stress | Sensorimotor cortex | Sprague-Dawley rat | Down |
| Study M752 | Type1 | PSD group vs. control group | Hippocampus | Wistar rat | Down |
| Study M752 | Type1 | PSD group vs. control group | Prefrontal cortex | Wistar rat | Down |
| Study M752 | Type2 | PSD + Yi-nao-jie-yu decoction group vs. PSD group | Hippocampus | Wistar rat | Up |
| Study M752 | Type2 | PSD + Yi-nao-jie-yu decoction group vs. PSD group | Prefrontal cortex | Wistar rat | Up |
| Study M785 | Type1 | MDD group vs. control group | Ventromedial prefrontal cortex | Human | Up |
| Study M864 | Type2 | psilocybin group, posttreatment vs. baseline | Anterior cingulate cortex | Human | Down |
| Study M944 | Type1 | MDD group vs. control group | Pregenual anterior cingulate cortex | Human | Up |